Processa Pharmaceuticals Stock Volatility
| PCSA Stock | USD 2.98 -0.01 -0.33% |
Sharpe Ratio = 0.0229
| Leading Returns | Top Quartile | |||
| Strong | ||||
| Moderate | ||||
| Modest | PCSA | |||
| Cash | Low | Moderate | Elevated | High |
| Below Benchmark |
Latest disclosures for Processa Pharmaceuticals show a Market Risk Adjusted Performance of 0.1%, a Risk of 6.67, and a Risk Adjusted Performance of 0.02%. The stock is currently at approximately 1% of its recent trend range per monthly moving averages.
Key indicators related to Processa Pharmaceuticals' volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Key risk metrics for Processa Pharmaceuticals (3 Months):
Beta 0.75 | Alpha 0.0921 | Risk 6.67 | Sharpe Ratio 0.0229 | Expected Return 0.15 |
Moving together with Processa Stock
Moving Against Processa Stock
Sensitivity To Market
Processa Pharmaceuticals beta coefficient measures the volatility of Processa stock relative to the systematic risk of the broad market benchmark. A beta of 0.75 indicates the degree of sensitivity to market-wide movements. Current total volatility is approximately 6.67%. Processa Pharmaceuticals has shown noticeable price swings over the selected period. Downside deviation is about 7.35% and standard deviation is about 6.56%, which summarize how widely returns have moved. Equity volatility compresses in calm markets and expands quickly when uncertainty increases. Stock dispersion changes materially during earnings seasons and macro data releases.
3 Months Beta |Processa Pharmaceuticals Demand TrendCurrent 90-day Processa Pharmaceuticals correlation with market (Dow Jones Industrial)Downside Risk
Standard deviation measures how far Processa returns deviate from the historical mean and remains a primary indicator of total price volatility. A large standard deviation signals wide price swings; a small one signals relative stability.
Standard Deviation | 6.67 |
For Processa Pharmaceuticals, the distinction between upside and downside risk matters. Downside risk, the risk of loss specifically, is better measured by semi-deviation or downside deviation of Processa Pharmaceuticals' returns. Latest disclosures for Processa Pharmaceuticals show a Downside Deviation of 7.35, a Downside Variance of 54.00, and a Maximum Drawdown of 37.67.
Stock Volatility Analysis
Volatility describes the degree to which Processa Pharmaceuticals stock price fluctuates in either direction. It captures how much Processa Pharmaceuticals' price fluctuates, which is relevant to allocation calibration.
Transformation |
This analysis covers sixty-one data points across the selected time horizon. The Average Price transformation calculates the mean of Processa Pharmaceuticals's open, high, low, and close for each trading period. By incorporating all four price components equally, it provides a balanced representation of each period's trading activity. Compared to using the closing price alone, the average price reduces the influence of end-of-day positioning and can serve as a smoother input for other technical indicators.
Projected Return Density Against Market
Given a 90-day horizon, Processa Pharmaceuticals has a beta of 0.7503 indicating as returns on the market go up, Processa Pharmaceuticals's average returns tend to increase less than the benchmark. However, during a bear market, the loss from holding Processa Pharmaceuticals tends to be smaller as well.Processa Pharmaceuticals remains sensitive to broader stock market conditions in addition to company or sector-specific developments. Portfolio diversification mitigates only part of this exposure. Latest disclosures for Processa Pharmaceuticals show a Downside Deviation of 7.35, a Mean Deviation of 4.84, and a Semi Deviation of 6.90.
Predicted Return Distribution |
| Density |
What Drives Processa Pharmaceuticals' Price Volatility?
Industry Dynamics
Regulatory updates, demand shifts, and competitive changes in the Biotechnology sector can move Processa Pharmaceuticals' volatility even when broad indices are stable.Political and Economic Environment
Rates, inflation expectations, and policy headlines can shift discount rates and risk appetite for Processa Pharmaceuticals.Processa Pharmaceuticals' Company-Specific Factors
Earnings surprises, guidance changes, management decisions, and litigation risk are common catalysts for sharp re-pricing in Processa Pharmaceuticals' shares.Stock Risk Measures
Given a 90-day horizon, the coefficient of variation of Processa Pharmaceuticals is 4363.83. The daily returns are distributed with a variance of 44.45 and standard deviation of 6.67. The mean deviation of Processa Pharmaceuticals is currently at 4.9. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.94
α | Alpha over Dow Jones | 0.09 | |
β | Beta against Dow Jones | 0.75 | |
σ | Overall volatility | 6.67 | |
Ir | Information ratio | 0.01 |
Stock Return Volatility
Processa Pharmaceuticals historical daily return volatility represents how much of Processa Pharmaceuticals stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company reported 6.6672% volatility on return distribution over a 90-day investment horizon. By contrast, Dow Jones Industrial reported 0.9502% volatility on return distribution over a 90-day investment horizon. Performance |
| Timeline |
Related Correlations Analysis
Please upgrade your account to get full access to Macroaxis premium features
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
Strong recent returns in Processa Stock do not always mean Processa Pharmaceuticals Company is outperforming peers on business quality. Peer-relative risk metrics add context on drawdown behavior, consistency, and return quality. These indicators are quantitative in nature and measure volatility and risk-adjusted expected returns across different positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BCTX | 3.29 | -0.16 | 0.00 | 0.31 | 0.00 | 6.27 | 23.17 | |||
| CRIS | 4.43 | -0.53 | 0.00 | 1.75 | 0.00 | 9.20 | 37.24 | |||
| ENTO | 7.46 | -0.08 | 0.00 | 0.08 | 0.00 | 16.86 | 39.61 | |||
| LPTX | 14.85 | 6.60 | 0.64 | -3.88 | 6.90 | 25.00 | 65.13 | |||
| PALI | 4.27 | 0.41 | 0.07 | 0.33 | 5.22 | 10.34 | 30.02 | |||
| HOTH | 4.21 | -0.20 | 0.00 | 0.49 | 0.00 | 9.09 | 48.52 | |||
| MBRX | 3.92 | -0.66 | 0.00 | -0.38 | 0.00 | 5.79 | 54.51 | |||
| ATHA | 5.04 | 1.37 | 0.28 | 0.81 | 4.00 | 9.87 | 72.52 | |||
| ALLR | 3.99 | 0.43 | 0.09 | 0.71 | 4.20 | 10.43 | 29.05 | |||
| CTXR | 4.72 | 0.42 | 0.08 | -0.29 | 4.80 | 11.11 | 40.49 |
Risk Metrics, Assumptions & Methodology
Drawdown depth for Processa Pharmaceuticals defines the worst peak-to-trough loss observed, framing downside volatility in practical terms. Comparing drawdown depth across market phases shows whether downside risk is regime-dependent. Processa Pharmaceuticals has a market cap of 7.95 M, ROE of -3.73%.
Reported values for Processa Pharmaceuticals are derived from periodic company reporting and market reference feeds and standardized for analysis. Analyst projections are included when active coverage applies. Volatility and downside metrics are estimated from historical return dispersion.
Editorial review and methodology oversight provided by: Rifka Kats, Member of Macroaxis Editorial Board
Processa Pharmaceuticals Volatility Profile Summary
Recent data suggests that Processa Pharmaceuticals is more volatile than Dow Jones Industrial by approximately 7.02x over the selected horizon. This differential reflects the relative dispersion of returns and frames how the asset responds to broader market conditions. Observed price behavior indicates modest directional movement within the current volatility regime. Across the current 90-day horizon, that places the security below 59% of the broader equity and portfolio universe on a pure volatility basis. This positioning reflects relative dispersion compared to peers rather than extreme instability.Processa Pharmaceuticals exhibits characteristics that tend to dampen sensitivity to smaller market fluctuations within the current volatility regime. This price-change note interprets the latest move in the context of short-horizon trading behavior. It gains reliability when combined with broader risk controls and volatility-adjusted analysis. Observed price behavior reflects modest downward movement with limited trading activity. Return distributions derived from historical modeling outline a range of potential outcomes over the selected 90-day horizon. View Processa Pharmaceuticals probability analysis.
Excellent diversification
Processa Pharmaceuticals currently posts a -0.07 correlation with Dow Jones, indicating a Excellent diversification relationship for the active sample. The overlap area shows the portion of risk diversified away by holding both instruments together.
Processa Pharmaceuticals Additional Risk Indicators
Looking at additional risk metrics for Processa Pharmaceuticals frames how the position may behave under different market and portfolio conditions. The practical goal is to identify how much risk is being accepted and whether that risk still fits the thesis.
| Risk Adjusted Performance | 0.0231 | |||
| Market Risk Adjusted Performance | 0.1319 | |||
| Mean Deviation | 4.84 | |||
| Semi Deviation | 6.9 | |||
| Downside Deviation | 7.35 | |||
| Coefficient Of Variation | 6463.74 | |||
| Standard Deviation | 6.56 |
Processa Pharmaceuticals Suggested Diversification Pairs
Pair trading with Processa Pharmaceuticals hedges company-specific exposure by balancing a long view with an offsetting position. This structure emphasizes relative performance differences between paired assets rather than broad market direction.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Processa Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Processa Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Processa Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Processa Pharmaceuticals.
Popular Tools for Processa Stock analysis
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideasPortfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfoliosPrice Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple marketsPortfolio ProphetUse AI to generate optimal portfolios and find investment opportunitiesEquity SearchSearch for actively traded equities including funds and ETFs from over 30 global marketsFundamental AnalysisView fundamental data based on most recent published financial statementsBalance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratiosCommodity DirectoryFind actively traded commodities issued by global exchangesInsider ScreenerFind insiders across different sectors to evaluate their impact on performance